Marcus & Millichap (MMI) Stock Could Be 5% Overvalued After Brown And Brown Partnership
Marcus & Millichap, Inc. MMI | 0.00 |
Marcus & Millichap (MMI) is drawing investor interest after announcing a partnership with Brown & Brown, Inc., which gives commercial real estate clients access to insurance indications, portfolio analysis, and broader risk management support.
Alongside the Brown & Brown partnership and recent deal activity in markets like Beverly Hills and San Francisco, Marcus & Millichap’s share price return has been mixed, with a 90-day share price return of 12.94% contrasting with a 1-year total shareholder return that declined 2.85%. This suggests that shorter term momentum is stronger than longer term results.
If this kind of deal flow has your attention, it could be a good time to widen your search and check out 20 top founder-led companies
So with Marcus & Millichap posting mixed long term returns, recent revenue and net income growth, and a share price near US$29, is the stock still undervalued or are markets already pricing in future growth?
Most Popular Narrative: 5% Overvalued
At a last close of $29.32 versus a narrative fair value of $28, Marcus & Millichap is framed as slightly expensive, with analysts leaning on detailed long term assumptions to justify that view.
The analysts have a consensus price target of $28.0 for Marcus & Millichap based on their expectations of its future earnings growth, profit margins and other risk factors.
In order for you to agree with the analysts, you would need to believe that by 2029, revenues will be $1.1 billion, earnings will come to $81.3 million, and it would be trading on a PE ratio of 15.2x, assuming you use a discount rate of 8.5%.
Want to understand why this fair value sits only slightly below today’s share price? The narrative leans heavily on a sharp earnings recovery, firmer margins, and a future valuation multiple that contrasts with where the stock is today. The real tension is how quickly Marcus & Millichap can move from current losses to those projected profit levels.
Result: Fair Value of $28 (OVERVALUED)
However, this hinges on Marcus & Millichap managing fee pressure and avoiding a prolonged slowdown in commission-based transaction volumes that could keep profitability under strain.
Another View: Marcus & Millichap Through The DCF Lens
While the analyst narrative describes Marcus & Millichap as around 5% overvalued using earnings and multiples, the Simply Wall St DCF model presents a very different perspective. It suggests a fair value estimate of $418.48 compared with the current $29.32 share price, or roughly 93% below that estimate. This raises the question of how an investor might weigh such a wide gap between two valuation frameworks.
For a closer look at how those long term cash flow assumptions are constructed, and how sensitive they might be to changes in margins or transaction volumes, it can be useful to walk through the full SWS DCF model in detail, starting with Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Marcus & Millichap for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 45 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
Given the mixed sentiment around Marcus & Millichap, it makes sense to review the data directly and weigh both the concerns and the upside before forming a view, especially with 2 key rewards and 1 important warning sign
Looking for more investment ideas beyond Marcus & Millichap?
If you are weighing up Marcus & Millichap today, it makes sense to scan a wider field of opportunities using focused screeners that surface specific strengths and characteristics.
- Zero in on higher yield opportunities by checking companies that feature resilient payouts and consistent income profiles with the 8 dividend fortresses
- Spot potentially mispriced opportunities early by reviewing companies that combine quality fundamentals with appealing valuations through the 45 high quality undervalued stocks
- Prioritize capital preservation first by focusing on companies that score well on financial resilience and risk with the 65 resilient stocks with low risk scores
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
